Search results
Jump to navigation
Jump to search
Page title matches
- Name = Breast cancer | ...r.<ref name="who fact sheet"/> Decade by decade, medical understanding of breast cancer, and treatments available for it, have grown. As of 2024, it is often poss101 KB (14,716 words) - 09:04, 5 April 2024
- 12 bytes (1 word) - 15:04, 25 September 2007
- 74 bytes (9 words) - 08:58, 23 June 2008
- 131 bytes (19 words) - 02:07, 23 September 2008
- .../www.nationmaster.com/graph/hea_bre_can_inc-health-breast-cancer-incidence Breast cancer incidence by country] * [http://foundation.nsabp.org/ NSABP- Breast Cancer Research Clinical Trials Group]666 bytes (91 words) - 07:28, 9 March 2009
- 147 bytes (16 words) - 06:08, 5 April 2024
Page text matches
- .../www.nationmaster.com/graph/hea_bre_can_inc-health-breast-cancer-incidence Breast cancer incidence by country] * [http://foundation.nsabp.org/ NSABP- Breast Cancer Research Clinical Trials Group]666 bytes (91 words) - 07:28, 9 March 2009
- ...r]] [[gene]] associated with DNA repair and, when mutated, with familial [[breast cancer|breast]] and [[ovarian cancer|ovarian]] [[cancer]].193 bytes (23 words) - 12:02, 24 October 2010
- ...r]] [[gene]] associated with DNA repair and, when mutated, with familial [[breast cancer|breast]] and [[ovarian cancer|ovarian]] [[cancer]].193 bytes (23 words) - 12:03, 24 October 2010
- ...21. Mutations of this gene are associated with the formation of familial [[breast cancer|breast]] and [[ovarian cancer|ovarian]] cancer. It encodes a large, nuclear ...r [[BRCA2 gene]] mutations, especially if there is a familial history of [[breast cancer]], may be candidates for prophylactic [[mastectomy]]. <ref>{{citation886 bytes (120 words) - 11:57, 24 October 2010
- ....3. Mutations of this gene are associated with the formation of familial [[breast cancer|breast]] and [[ovarian cancer|ovarian]] cancer. It encodes a large, nuclear ...ene|BRCA1]] or BRCA2 genes, especially if there is a familial history of [[breast cancer]], may be candidates for prophylactic [[mastectomy]]. <ref>{{citation965 bytes (129 words) - 22:06, 22 August 2010
- ...onoclonal antibody]] useful in treatment of [[HER2]]-positive metastatic [[breast cancer]]131 bytes (15 words) - 07:56, 5 February 2009
- Exocrine glands, in mammals, which produce milk; often the origin of [[breast cancer]]122 bytes (16 words) - 11:32, 18 August 2010
- {{r|breast cancer}}313 bytes (45 words) - 12:09, 24 October 2010
- {{r|breast cancer}}313 bytes (45 words) - 12:10, 24 October 2010
- {{r|Breast cancer}}506 bytes (66 words) - 10:52, 11 January 2010
- {{r|Breast cancer}}212 bytes (27 words) - 17:18, 17 August 2009
- An invasive and metastatic form of [[breast cancer]], of a [[adenocarcinoma|class of cancers]] derived from [[epithelial cell]211 bytes (30 words) - 11:41, 4 August 2010
- {{r|Breast cancer}}569 bytes (73 words) - 18:12, 11 January 2010
- {{r|Breast cancer}}706 bytes (92 words) - 19:45, 11 January 2010
- ...evacizumab]] ||Non-small cell [[lung cancer|lung carcinoma]] (NSCLC)<br/>[[Breast cancer]]<br/>[[Colorectal cancer]]1 KB (171 words) - 09:06, 9 September 2020
- {{r|Breast cancer}}374 bytes (41 words) - 12:15, 17 May 2023
- Patients who took it are at slightly increased risk of developing breast cancer.2 KB (233 words) - 11:16, 7 September 2008
- {{r|Breast cancer}}812 bytes (102 words) - 19:58, 11 January 2010
- ...matase inhibitor]]s, tamoxifen was the gold standard for chemotherapy of [[breast cancer]], and remains important in its treatment, especially of premenopausal wome ...n, Lawrence F Paszat | title = Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study2 KB (211 words) - 19:00, 2 July 2010
- {{r|Breast cancer}}487 bytes (64 words) - 19:21, 11 January 2010
- {{r|Breast cancer}}482 bytes (62 words) - 21:42, 11 January 2010
- {{r|Breast cancer}}517 bytes (67 words) - 19:07, 11 January 2010
- {{r|Breast cancer}}718 bytes (112 words) - 11:31, 29 December 2010
- ...izes it as indicated for: [[glioma|glioblastoma multiforme]], metastatic [[breast cancer|breast carcinoma]], metastatic [[colorectal cancer]], [[lung cancer|non-sma | title = FDA says breast cancer drug did not extend lives3 KB (376 words) - 14:53, 17 July 2010
- ...used to treat cancerous tumors, which are estrogen-sensitive, especially [[breast cancer]] in postmenopausal women. At present, three AIs are approved by the FDA<r610 bytes (69 words) - 03:15, 7 October 2013
- 1 KB (194 words) - 22:25, 19 August 2010
- {{r|Breast cancer}}929 bytes (121 words) - 18:00, 1 April 2024
- ...e [[ErbB-2 receptor]] (HER2) that lengthens remission time in metastatic [[breast cancer]].<ref name="pmid17611206">{{cite journal| author=Hudis CA| title=Trastuzum707 bytes (88 words) - 11:35, 23 March 2010
- {{r|Breast cancer}}461 bytes (59 words) - 21:41, 11 January 2010
- {{r|Breast cancer}}457 bytes (58 words) - 21:04, 11 January 2010
- {{r|Breast cancer}}470 bytes (61 words) - 18:12, 11 January 2010
- {{r|Breast cancer}}548 bytes (71 words) - 10:55, 11 January 2010
- {{r|Breast cancer}}508 bytes (66 words) - 11:03, 11 January 2010
- {{r|Breast cancer}}640 bytes (83 words) - 18:38, 11 January 2010
- {{r|Breast cancer}}635 bytes (81 words) - 18:26, 11 January 2010
- {{r|Breast cancer}}2 KB (310 words) - 12:22, 18 April 2024
- {{r|Breast cancer}}669 bytes (88 words) - 19:44, 11 January 2010
- ...dis/table.asp P450 Drug Interaction Table]</ref> May increase death from [[breast cancer]] among women taking [[tamoxifen]] due to inhibiting metabolism of [[tamoxi ...n, Lawrence F Paszat | title = Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study3 KB (345 words) - 09:46, 13 February 2011
- {{r|Breast cancer}}2 KB (203 words) - 11:57, 11 January 2010
- {{r|Breast cancer}}819 bytes (107 words) - 20:53, 11 January 2010
- ...n, Lawrence F Paszat | title = Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study2 KB (279 words) - 11:00, 10 February 2010
- {{r|Breast cancer}}839 bytes (106 words) - 16:24, 11 January 2010
- ...filtrating intraductal carcinoma''', is "a noninvasive (noninfiltrating) [[breast cancer|carcinoma of the breast]] characterized by a proliferation of malignant epi2 KB (227 words) - 11:32, 29 December 2010
- {{r|Breast cancer}}890 bytes (112 words) - 20:45, 11 January 2010
- ...n, Lawrence F Paszat | title = Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study3 KB (483 words) - 17:34, 10 February 2024
- {{r|Breast cancer}}1 KB (136 words) - 18:54, 6 February 2012
- ...al| author=Esserman L, Shieh Y, Thompson I| title=Rethinking screening for breast cancer and prostate cancer. | journal=JAMA | year= 2009 | volume= 302 | issue= 15 ...Andersson I, Janzon L, Manjer J, Garne JP |title=Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study8 KB (1,174 words) - 07:48, 28 August 2013
- ...title=Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. | journal=Obstet Gynecol | year=1 KB (183 words) - 07:58, 5 July 2011
- {{r|Breast cancer}}2 KB (219 words) - 21:43, 11 January 2010
- ...OP, Shapiro S, Tuominen L, Turunen MI| title=Reserpine use in relation to breast cancer. | journal=Lancet | year= 1974 | volume= 2 | issue= 7882 | pages= 675-7 | p ...Curb JD, Hardy RJ, Labarthe DR, Borhani NO, Taylor JO| title=Reserpine and breast cancer in the Hypertension Detection and Follow-Up Program. | journal=Hypertension8 KB (1,032 words) - 13:06, 21 June 2012
- ...against the ErbB-2 receptor that lengthens remission time in metastatic [[breast cancer]].<ref name="pmid17611206">{{cite journal| author=Hudis CA| title=Trastuzum2 KB (308 words) - 06:03, 16 July 2010
- ...HER2 (Entrez protein) antibody that lengthens remission time in metastatic breast cancer."4 KB (467 words) - 00:17, 6 February 2009
- ===Breast cancer=== ...midlookup?view=short&pmid=19297566&promo=ONFLNS19 |issn=}}</ref> Regarding breast cancer, about 50% of cancers represent overdiagnosis; this fraction is reduced to20 KB (2,861 words) - 14:14, 26 July 2017
- ...title=Vaginal pH-Balanced Gel for the Control of Atrophic Vaginitis Among Breast Cancer Survivors: A Randomized Controlled Trial. | journal=Obstet Gynecol | year=3 KB (372 words) - 23:06, 21 April 2011
- ...inst the [[ErbB-2 receptor]] that lengthens remission time in metastatic [[breast cancer]]."<ref>{{MeSH|Trastuzumab [Substance Name]}}</ref>10 KB (1,356 words) - 06:07, 5 April 2024
- {{r|Breast cancer}}4 KB (505 words) - 16:36, 11 January 2010
- | title = Ancient chinese remedy shows potential in preventing breast cancer6 KB (877 words) - 21:22, 30 December 2009
- ...drug approved for use with a matching diagnostic test and is used to treat breast cancer in women whose cancer cells express the protein [[HER2]]. ...ing the fastest rates of growth against this background, particularly in [[breast cancer]] treatment. Biopharmaceuticals typically treat sub-sets of the total popu9 KB (1,266 words) - 18:41, 3 March 2024
- | journal = Breast Cancer Res. | year = 2007 | volume = 9(Suppl 2) | page= S9.9 KB (1,300 words) - 09:56, 28 January 2023
- ...nthesis may give rise to new strategies for the prevention or treatment of breast cancer.")13 KB (1,805 words) - 02:37, 16 February 2010
- 7 KB (919 words) - 14:12, 20 August 2010
- | title =Breast Cancer Res.5 KB (747 words) - 19:45, 23 January 2011
- ...t physicians inform patients of their options when they are diagnosed with breast cancer.10 KB (1,478 words) - 10:02, 1 April 2023
- ...): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer. [serial on the Internet]. 2007 May 15 [cited 2010, Oct. 7];12. Available f11 KB (1,563 words) - 03:38, 7 October 2013
- ...dotal example comes from a case in which a woman with end-stage metastatic breast cancer was told medicine had no cures available, and she sought alternative care f9 KB (1,415 words) - 21:25, 7 March 2011
- ...ne alone (no other types of insulin) had an increased incidence rate of [[breast cancer]] as compared with women using types of insulin other than insulin glargin ...en the overall data, we consider the excess of cases of all cancers and [[breast cancer]] in the subgroup of insulin glargine only users to more likely reflect al21 KB (2,988 words) - 06:24, 9 October 2013
- Name = Breast cancer | ...r.<ref name="who fact sheet"/> Decade by decade, medical understanding of breast cancer, and treatments available for it, have grown. As of 2024, it is often poss101 KB (14,716 words) - 09:04, 5 April 2024
- ...Prentice RL ''et al.'' |title=Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification T20 KB (2,783 words) - 11:52, 2 February 2023
- ...uce a chemical, [[Taxol]] (brand name) for [[paclitaxel]], useful against breast cancer.<ref name=ForesterYew>{{citation | title = Second breast cancer drug from yew tree - Food and Drug Administration approves Taxotere, or doc17 KB (2,485 words) - 17:34, 10 February 2024
- ...not penalised. [[Agata]], an organisation in [[Catalonia]] which supports breast cancer patients, is demanding legal availability of marijuana for patients who are8 KB (1,179 words) - 10:09, 28 February 2024
- ...juries. Symptoms did not exacerbate in a randomized controlled trial of 45 breast cancer survivors.<ref name=>{{citation | title = Randomized controlled trial of weight training and lymphedema in breast cancer survivors21 KB (2,921 words) - 23:03, 22 May 2013
- * [[Breast cancer]]29 KB (3,995 words) - 11:45, 2 February 2023
- .... The most common types are lung cancer (with only 12% surviving 5 years), breast cancer (80% survival), colon cancer (60%), and prostrate cancer (80%). Breast cancer </TD><TD QP::NUMFORMAT:="34,-1,0.15">37 KB (5,563 words) - 14:08, 2 February 2023
- ...Administrator of the Year before she passes away after a long battle with breast cancer. In April 2005, she is posthumously awarded the CASE Harrie Selznick Award,10 KB (1,603 words) - 10:19, 30 July 2023
- ...Turner B, Amsel Z, Lustbader E, Schwartz J, Balshem A, Grisso J | title = Breast cancer screening: effect of physician specialty, practice setting, year of medical25 KB (3,536 words) - 05:23, 25 November 2020
- :*Why breast cancer?11 KB (1,649 words) - 13:38, 16 May 2024
- ...gnificantly increased risk of subsequent diagnosis of cancer, especially [[breast cancer]] and [[prostate cancer]].<ref name="pmid12794837">{{cite journal |author=M25 KB (3,339 words) - 07:16, 2 July 2014
- ...e=en-US|access-date=2018-12-02}}</ref> In May 2023, she was diagnosed with breast cancer. <ref>{{Cite web|url=https://marthawells.dreamwidth.org/621645.html|title=L22 KB (3,059 words) - 00:02, 22 January 2024
- ...y not be a good analogy, but my feeling is similar, starting an article on breast cancer with an account of what we don't know is not what we would choose to do.[[U12 KB (2,066 words) - 12:50, 12 March 2007
- ...operation called radical [[mastectomy]], which provided the only cures for breast cancer in his era. He introduced regional [[anesthesia]].11 KB (1,733 words) - 11:25, 5 May 2011
- ...her studies suggest that nighttime exposure to light increases the risk of breast cancer by inhibiting the normal nighttime surge of melatonin, which may decrease t31 KB (4,553 words) - 18:17, 18 July 2016
- She developed [[breast cancer]] in 1907, and was treated by Dr. Edward Bloch, a Jewish physician to whom15 KB (2,407 words) - 12:47, 2 April 2024
- ...al. (2008) Incidence of fractures compared to cardiovascular disease and breast cancer: The Women's Health Initiative observational study. ''Osteoporosis Internat49 KB (6,739 words) - 13:28, 10 February 2023
- :*why the modern high incidence of breast cancer50 KB (7,332 words) - 17:37, 18 July 2016
- She developed [[breast cancer]] in 1907, and was treated by Dr. Edward Bloch, a Jewish physician to whom19 KB (3,101 words) - 12:48, 2 April 2024
- {{cite journal | author = Turner B ''et al.'' | title = Breast cancer screening: effect of physician specialty, practice setting, year of medical27 KB (3,605 words) - 11:27, 2 December 2013
- ...bonomics-based projects investigating fatty liver disease, [[diabetes]], [[breast cancer]], burns and other medical conditions.21 KB (2,958 words) - 05:06, 8 March 2024
- ...e [[pornographic]] material, specialists in [[gynecology]], [[urology]], [[breast cancer]], and other fields cannot be blocked, by Web content filters, from their25 KB (3,794 words) - 05:48, 8 April 2024
- ...ne responses after brief psychological stress in women at familial risk of breast cancer.] ''Psychoneuroendocrinology'' 28:584-93. ...rine reactivity to acute psychological stress in women at familial risk of breast cancer. The heightened endocrine reactivity to the experimental tasks seen here su243 KB (35,084 words) - 07:35, 10 April 2024
- ...name="pmid1599724">{{cite journal | author = Turner B ''et al.'' | title = Breast cancer screening: effect of physician specialty, practice setting, year of medical55 KB (7,444 words) - 06:21, 29 August 2013
- 59 KB (8,548 words) - 15:04, 15 April 2024
- ...name="pmid1599724">{{cite journal | author = Turner B ''et al.'' | title = Breast cancer screening: effect of physician specialty, practice setting, year of medical63 KB (8,790 words) - 06:57, 2 March 2021